MedPath

The Study of Vitamin D Supplement-aid in the treatment of Helicobacter Pylori eradicatio

Phase 3
Recruiting
Conditions
Dyspepsia due to Helicobacterpylori.
Functional dyspepsia
Registration Number
IRCT20180922041089N2
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Age over 18 years
A test of the fecal antigen of the Helicobacter pylori or Rapid urease test (RUT) is positive
All patients with functional dyspepsia of the pseudo-ulcer type who did not respond to (or recurring) acid reflux therapy, or the presence or history of gastric or duodenal peptic ulcer in a patient or first-degree relatives of patients with gastric cancer
Informed consent Form

Exclusion Criteria

The history of epilepsy
History of chronic diseases (CHB, CKD, COPD, recurrent CVA or dementia, liver cirrhosis)
Patients own cancers
Severe psychiatric illnesses such as schizophrenia, major depression, bipolar disorders
History of antibiotic use in the last 6 weeks
Patients with dyspepsia with a predominant symptom of reflux
Drug, alcohol and cigarettes
History of gastric surgeries, IBD, diabetes, pathological weight loss (weight loss over 10% of body weight over the past 6 months)
Anemia (Hemoglobin in men under 14 in males under 11 and in menopausal women under 12 (1))
Diabetes (if FBS is greater than or equal to 126 or HbA1c greater than or equal to 6.5%)
corticosteroids use in the last 3 months
Use of vitamin D supplements with therapeutic doses during the last 3 months or during the study
Participate in another research project over the past 3 months
Pregnancy or breastfeeding
History of H pylori infection treatment in the past
History of kidney stones
Participants' unwillingness to take medication or placebo
History of any allergy or side effects
BMI greater than 40

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath